FBI Alleges Another Insider Trading Case Involving "Consultants"Mark Melin
The New York FBI has cracked another insider trading case, this time involving employees at the $7 billion Deerfield Management, a high-profile hedge fund whose managing partner warned in 2015 against investing in Valeant Pharmaceuticals due to its unsavory pricing practices.
Insider trading allegations: Deerfield accused of accessing improper information
In 2015, with Valeant stock trading over $100 per share, Deerfield’s New York-based Managing Partner Jim Flynn Sign up here
If you are subscribed and having an account error please clear cache and cookies if that does not work email firstname.lastname@example.org or click chat